Homeovitality is an entirely new concept in health promotion. For the first time ever, Homeovitality helps everyone to benefit from new "cutting-edge" genetic discoveries right now using a safe, drug free delivery system.
In 1997, Prof. Khuda-Bukhsh proposed that homeopathic substances have the capacity to interact with the genetic blueprint and deliver their benefits by increasing the expression of genes that synthesise health promoting proteins. Since then, work by Prof. Khuda-Bukhsh [2, and within Ref. 2] and other scientists  have clearly demonstrated that homeopathic substances do have the capacity to do this.
The genetic blueprint contains many genes that promote health as well as many genes that cause disease. With a view to increasing the specificity and safety of gene targeting by homeopathic DNA, (because homeopathic DNA, which is of undefined sequence, induces various disease symptoms in healthy people) Drs. Jenaer and Marichal pioneered the use of highly diluted small DNA molecules with well-defined sequences to target immune response genes and fight infections. Their system, called Micro-Immunotherapy proved to be very effective. The Homeovitality system was developed along the same lines as Micro-Immunotherapy.
The Homeovitality system uses highly diluted DNA molecules with precise sequences to target genes that produce the body's natural proteins that have been proven to promote health as well as protect against and resolve many diseases.
Khuda-Bukhsh AR: Potentized homeopathic drugs act through regulation of gene expression: a hypothesis to explain their mechanism and pathways of action in vivo. Com Ther Med. 1997: 5; 43.
Saha S K et al., Phenotypic evidence of ultra-highly diluted homeopathic remedies acting at gene expression level: a novel probe on experimental phage infectivity in bacteria. Zhong Xi Yi Jie He Xue Bao. 2012:10; 462.
Sunila et al., Dynamized preparations in cell culture. Evidence-Based Comp. Alt. Med., 2009:6:257.
Frenkel et al., Cytotoxic effects of ultra-diluted remedies on breast cancer cells. Int J Oncol., 2010: 36:395, 2010.
For further info: